8 September 2015

Board Changes

VERONA PHARMA PLC - Board Changes

Read more

8 September 2015

Half-yearly Report

VERONA PHARMA PLC - Half-yearly Report

Read more

27 August 2015

Notice of Results

VERONA PHARMA PLC - Notice of Results

Read more

7 July 2015

Director Dealing

VERONA PHARMA PLC - Director Dealing

Read more

17 June 2015

Director Dealings

VERONA PHARMA PLC - Director Dealings

Read more

12 June 2015

Secondary listing in Germany

VERONA PHARMA PLC - Secondary listing in Germany

Read more

11 June 2015

RPL554 Phase 2a trial started

VERONA PHARMA PLC - RPL554 Phase 2a trial started

Read more

11 June 2015

Result of AGM

VERONA PHARMA PLC - Result of AGM

Read more

8 June 2015

RPL554 MAD study complete

VERONA PHARMA PLC - RPL554 MAD study complete

Read more

18 May 2015

Director/PDMR Shareholding

Verona Pharma plc

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us